IL134240A0 - Inositol derivatives and their pharmaceutical use - Google Patents
Inositol derivatives and their pharmaceutical useInfo
- Publication number
- IL134240A0 IL134240A0 IL13424000A IL13424000A IL134240A0 IL 134240 A0 IL134240 A0 IL 134240A0 IL 13424000 A IL13424000 A IL 13424000A IL 13424000 A IL13424000 A IL 13424000A IL 134240 A0 IL134240 A0 IL 134240A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical use
- inositol derivatives
- inositol
- derivatives
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13424000A IL134240A0 (en) | 2000-01-27 | 2000-01-27 | Inositol derivatives and their pharmaceutical use |
PCT/IL2001/000079 WO2001055083A1 (en) | 2000-01-27 | 2001-01-26 | Inositol derivatives and their pharmaceutical use |
AU2001228784A AU2001228784A1 (en) | 2000-01-27 | 2001-01-26 | Inositol derivatives and their pharmaceutical use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13424000A IL134240A0 (en) | 2000-01-27 | 2000-01-27 | Inositol derivatives and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134240A0 true IL134240A0 (en) | 2001-04-30 |
Family
ID=11073753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13424000A IL134240A0 (en) | 2000-01-27 | 2000-01-27 | Inositol derivatives and their pharmaceutical use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001228784A1 (en) |
IL (1) | IL134240A0 (en) |
WO (1) | WO2001055083A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20060026A1 (en) * | 2006-01-10 | 2007-07-11 | Truffini & Regge Farmaceutici Srl | COMPOSITIONS FOR USE ON THE BASIS OF S-ADENOSYLMETHIONINE AND PROCESS FOR THEIR ACHIEVEMENT |
CN102336664B (en) * | 2010-07-16 | 2015-05-13 | 丰益(上海)生物技术研发中心有限公司 | Inosite fatty acid ester, its preparation method and its application |
US10383839B2 (en) | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
GB2560380B (en) | 2017-03-10 | 2020-04-01 | Crop Intellect Ltd | Agrochemical combination |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA814407A (en) * | 1969-06-03 | W. Price Clifford | Treatment of hypertension | |
US2997490A (en) * | 1959-05-08 | 1961-08-22 | Procter & Gamble | Method for preparing fatty esters |
GB1140520A (en) * | 1966-07-19 | 1969-01-22 | Shell Int Research | Novel cationic ester compounds, novel polymers and copolymers thereof, their preparation and use |
DE2659666A1 (en) * | 1976-12-30 | 1978-07-13 | Nattermann A & Cie | MEDICINAL PRODUCTS THAT PROVIDE BLOOD |
JPS57130923A (en) * | 1981-02-07 | 1982-08-13 | Eiji Sakata | Remedy and preventive for vertigo |
US4474806A (en) * | 1982-05-10 | 1984-10-02 | Merck & Co., Inc. | Sulfonyl or carbonyl inositol derivatives useful as anti-inflammatory/analgesic agents |
IL118180A (en) * | 1996-05-08 | 2000-12-06 | Modus Biolog Membranes Ltd | Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation |
-
2000
- 2000-01-27 IL IL13424000A patent/IL134240A0/en unknown
-
2001
- 2001-01-26 WO PCT/IL2001/000079 patent/WO2001055083A1/en active Application Filing
- 2001-01-26 AU AU2001228784A patent/AU2001228784A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001055083A1 (en) | 2001-08-02 |
AU2001228784A1 (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1367060A4 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
EP1364957A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
EP1364958A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
PT1296974E (en) | 2-cyanopyrrolidine derivatives and their use as medicaments | |
HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
HK1062914A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
HUP0200548A2 (en) | Pharmaceutical compositions and their use | |
EP1306387A4 (en) | Drugs or cosmetics | |
GB0020691D0 (en) | Pharmaceutical combination | |
HUP0300334A3 (en) | Pharmaceutical preparations and their manufacture | |
GB0012291D0 (en) | Pharmaceutical combination | |
IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
IL134240A0 (en) | Inositol derivatives and their pharmaceutical use | |
HUP0200812A2 (en) | Vitamin d analogues and their pharmaceutical use | |
GB0021487D0 (en) | Pharmaceutical | |
IL156032A0 (en) | Spiroindene derivatives and pharmaceutical compositions containing the same | |
IL128414A0 (en) | Inositol derivatives and their pharmaceutical use | |
GB0012293D0 (en) | Pharmaceutical combination | |
EP1414417A4 (en) | Pharmaceutical formulation | |
GB0028565D0 (en) | Pharmaceutical use | |
GB0014420D0 (en) | Pharmaceutical compositions and their use |